BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16721006)

  • 1. Sterile solutions and peritoneal inflammation.
    Flessner MF
    Contrib Nephrol; 2006; 150():156-165. PubMed ID: 16721006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation from sterile dialysis solutions and the longevity of the peritoneal barrier.
    Flessner MF
    Clin Nephrol; 2007 Dec; 68(6):341-8. PubMed ID: 18184514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediators of inflammation and fibrosis.
    Lai KN; Tang SC; Leung JC
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S65-71. PubMed ID: 17556333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.
    Sandoval P; Loureiro J; González-Mateo G; Pérez-Lozano ML; Maldonado-Rodríguez A; Sánchez-Tomero JA; Mendoza L; Santamaría B; Ortiz A; Ruíz-Ortega M; Selgas R; Martín P; Sánchez-Madrid F; Aguilera A; López-Cabrera M
    Lab Invest; 2010 Oct; 90(10):1517-32. PubMed ID: 20531289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent concepts in the molecular biology of the peritoneal membrane - implications for more biocompatible dialysis solutions.
    Mortier S; De Vriese AS; Lameire N
    Blood Purif; 2003; 21(1):14-23. PubMed ID: 12566656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation in peritoneal dialysis.
    Lai KN; Leung JC
    Nephron Clin Pract; 2010; 116(1):c11-8. PubMed ID: 20460934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin-aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum?
    Nessim SJ; Perl J; Bargman JM
    Kidney Int; 2010 Jul; 78(1):23-8. PubMed ID: 20336052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of fibrosis on peritoneal transport.
    Flessner MF
    Contrib Nephrol; 2006; 150():174-180. PubMed ID: 16721008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors increasing severity of peritonitis in long-term peritoneal dialysis patients.
    Park MS
    Adv Ren Replace Ther; 1998 Jul; 5(3):185-93. PubMed ID: 9686629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure.
    López-Cabrera M; Aguilera A; Aroeira LS; Ramírez-Huesca M; Pérez-Lozano ML; Jiménez-Heffernan JA; Bajo MA; del Peso G; Sánchez-Tomero JA; Selgas R
    Perit Dial Int; 2006; 26(1):26-34. PubMed ID: 16538870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taming apoptosis in peritoneal dialysis.
    Santamaria B; Ucero AC; Benito-Martin A; Selgas R; Ruiz-Ortega M; Sanz AB; Egido J; Ortiz A
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S45-8. PubMed ID: 19270230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.
    Schaefer B; Bartosova M; Macher-Goeppinger S; Sallay P; Vörös P; Ranchin B; Vondrak K; Ariceta G; Zaloszyc A; Bayazit AK; Querfeld U; Cerkauskiene R; Testa S; Taylan C; VandeWalle J; Yap Y; Krmar RT; Büscher R; Mühlig AK; Drozdz D; Caliskan S; Lasitschka F; Fathallah-Shaykh S; Verrina E; Klaus G; Arbeiter K; Bhayadia R; Melk A; Romero P; Warady BA; Schaefer F; Ujszaszi A; Schmitt CP
    Kidney Int; 2018 Aug; 94(2):419-429. PubMed ID: 29776755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients.
    Zhou Q; Bajo MA; Del Peso G; Yu X; Selgas R
    Kidney Int; 2016 Sep; 90(3):515-24. PubMed ID: 27282936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C α inhibition prevents peritoneal damage in a mouse model of chronic peritoneal exposure to high-glucose dialysate.
    Wang L; Balzer MS; Rong S; Menne J; von Vietinghoff S; Dong L; Gueler F; Jang MS; Xu G; Timrott K; Tkachuk S; Hiss M; Haller H; Shushakova N
    Kidney Int; 2016 Jun; 89(6):1253-67. PubMed ID: 27142955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on mechanisms of ultrafiltration failure.
    Kim YL
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S123-7. PubMed ID: 19270200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose-induced mesothelial cell senescence and peritoneal neoangiogenesis and fibrosis.
    Witowski J; Ksiazek K; Jörres A
    Perit Dial Int; 2008 Nov; 28 Suppl 5():S34-7. PubMed ID: 19008538
    [No Abstract]   [Full Text] [Related]  

  • 18. The importance of biocompatibility in peritoneal dialysis solutions.
    Passlick-Deetjen J
    Perit Dial Int; 1993; 13 Suppl 2():S101-4. PubMed ID: 8399540
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis.
    Dobbie JW
    Perit Dial Int; 1992; 12(1):14-27. PubMed ID: 1347465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal fibrosis intervention.
    Kaneko K; Hamada C; Tomino Y
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S82-6. PubMed ID: 17556336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.